Purity and reliability are of paramount importance for a treatment given to some of the most vulnerable patients.
The USP Filgrastim for Bioassay RS helps manufacturers address these concerns.
Features of this Standard:
- Relative potency aligned with the WHO 2nd IS for Filgrastim
- For assignment of relative potency of filgrastim using the cell-based bioassay in the USP Filgrastim monograph
- Rigorously evaluated and tested in 7 collaborating laboratories
- Each ampule contains 96,815 IU of biological activity in a lyophilized format for added stability